Lintuzumab
Lintuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Lintuzumab is under investigation in clinical trial NCT00016159 (Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia).
| Trade Name | Lintuzumab |
| Generic | Lintuzumab |
| Lintuzumab Other Names | Lintuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lintuzumab
